Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 349 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Long-term outcomes Clear all

Conditions: Seasonal Affective Disorder
Interventions: Cognitive-Behavioral Therapy (CBT-SAD), Light Therapy; Behavioral · Other
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Methicillin-resistant Staphylococcus Aureus, Skin Infection
Interventions: TMP-SMX, DOXY; Drug
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 9 Years to 85 Years
Enrollment: 269 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 3
States / cities: Sylmar, California • Torrance, California • St Louis, Missouri

Conditions: Coronary Artery Disease
Interventions: CardioFlux Magnetocardiography; Diagnostic Test
Lead sponsor: Genetesis Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Presbyopia
Interventions: VisAbility™ Micro Insert; Device
Lead sponsor: VisDura, Inc.; Industry
Eligibility: 45 Years to 60 Years
Enrollment: 287 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 13
States / cities: Orange, California • San Diego, California • Honolulu, Hawaii + 10 more

Conditions: Prematurity
Interventions: Not listed
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: Up to 12 Years
Enrollment: 600 participants
Timeline: 2017 – 2023
U.S. locations: 11
States / cities: Jacksonville, Florida • Boston, Massachusetts • Minneapolis, Minnesota + 8 more

Conditions: Overweight, Obesity
Interventions: No treatment given; Other
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 45 Years and older
Enrollment: 3,439 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Plainsboro, New Jersey

Conditions: Neovascular Age-related Macular Degeneration
Interventions: CLS-AX; Drug
Lead sponsor: Clearside Biomedical, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 7
States / cities: Phoenix, Arizona • Mountain View, California • Sacramento, California + 4 more

Conditions: Breast Cancer
Interventions: Oncoplastic Breast Surgery; Procedure
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2045
U.S. locations: 2
States / cities: Boston, Massachusetts • Melrose, Massachusetts

Conditions: Dyslipidemia
Interventions: Evolocumab; Biological
Lead sponsor: Amgen; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 5,035 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 144
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 136 more

Conditions: Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease
Interventions: alglucosidase alfa; Biological
Lead sponsor: Genzyme, a Sanofi Company; Industry
Eligibility: Up to 24 Months
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2021
U.S. locations: 3
States / cities: Gainesville, Florida • Decatur, Georgia • Detroit, Michigan

Conditions: Peri-Implantitis
Interventions: Observation; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Diabetes Mellitus
Interventions: Albiglutide 30 mg, Albiglutide 50 mg, Albiglutide matching placebo; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 40 Years and older
Enrollment: 9,463 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 146
States / cities: Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 125 more

Conditions: Incisional Hernia
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Renal Dysfunction, Hypertension
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Phenylketonuria
Interventions: Sepiapterin; Drug
Lead sponsor: PTC Therapeutics; Industry
Eligibility: Up to 9 Years
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Arthropathy of Knee, Post Operative Pain, Opioid Use, Opioid Abuse, Opioid Misuse
Interventions: Opioid education in person, Opioid education via video; Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 80 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Hip Dysplasia, Legg-Calvâe-Perthes Disease, Avascular Necrosis of Hip
Interventions: Long-term Follow-up Surveys; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Nonmelanoma Skin Cancer
Interventions: Electronic Brachytherapy; Procedure
Lead sponsor: Xoft, Inc.; Industry
Eligibility: 41 Years and older
Enrollment: 369 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 4
States / cities: Los Gatos, California • San Diego, California • Las Vegas, Nevada

Conditions: Intestinal Failure
Interventions: AI-driven total parenteral nutrition (TPN); Device
Lead sponsor: Takeoff41, Inc.; Industry
Eligibility: Up to 6 Months
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Brain Tumor, Medulloblastoma, Pineoblastoma
Interventions: proton beam radiation; Radiation
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 3 Years to 25 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2021
U.S. locations: 2
States / cities: Boston, Massachusetts • Houston, Texas

Conditions: Cubital Tunnel Syndrome
Interventions: Ulnar Nerve Stimulation; Device
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Alzheimer's Disease, Mild Cognitive Impairment
Interventions: florbetapir F 18; Drug
Lead sponsor: Avid Radiopharmaceuticals; Industry
Eligibility: 50 Years and older
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 8
States / cities: Scottsdale, Arizona • Tucson, Arizona • Costa Mesa, California + 5 more

Conditions: Vaginal Prolapse
Interventions: AMS Prolapse Product; Device
Lead sponsor: ASTORA Women's Health; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 1,543 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Whitinsville, Massachusetts

Conditions: Diabetes Mellitus, Health Behavior, Diabetes Mellitus, Type 2, Group Meetings
Interventions: Personalized Health Planning Program Administration, Usual Care; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Optimizing Long-Term Outcomes for Winter Depression With CBT-SAD and Light Therapy

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes

Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients

Developmental Impact of NICU Exposures (DINE)

SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial

Extension Study to Evaluate the Long-term Outcomes of Subjects in the CLS-AX CLS1002-101 Study

Oncoplastic Surgery Outcomes Database

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension

Growth and Development Study of Alglucosidase Alfa

Long-term Surgical Therapeutic Outcomes of Peri-Implantitis

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Incisional Hernia Outcomes Study Using Parietex Composite Mesh

Effect of Obesity on Long-term Clinical Outcomes After Kidney Donation

A Study of Sepiapterin in Participants With Phenylketonuria (PKU)

Opioid Education in Total Knee Arthroplasty

Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment

Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.

AI-driven Total Parenteral Nutrition Platform

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

Electrical Nerve Stimulation of the Ulnar Nerve

Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)

Observational Data Collection of Surgical Outcomes in the Treatment of Vaginal Prolapse With AMS Products

T2D Pilot Study for Patients With Uncontrolled Type 2 Diabetes